ELI LILLY & Co — Director's Dealing 2012

Feb 16, 2012

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2011-12-31

Reporting Person: Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-16	Common Stock	G	40	$0.00	Disposed	51226	Direct
2011-12-20	Common Stock	G	20	$0.00	Disposed	51206	Direct
2011-12-29	Common Stock	G	20	$0.00	Disposed	51186	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6869	Indirect